Anti-Microbial Savior BioteQ Co., Ltd. (TPEX:6864)
Taiwan · Delayed Price · Currency is TWD 40.10
-1.00 (-2.43%)
Aug 26, 2026, 1:49 PM CST
TPEX:6864 Revenue
In the year 2025, Anti-Microbial Savior BioteQ had annual revenue of 706.00K TWD with 15.36% growth. Anti-Microbial Savior BioteQ had revenue of 267.00K in the half year ending December 31, 2024, with 203.41% growth.
Revenue
706.00K
Revenue Growth
+11.53%
P/S Ratio
2,201.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.55B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 706.00K | 94.00K | 15.36% |
| Dec 31, 2024 | 612.00K | -116.00K | -15.93% |
| Dec 31, 2023 | 728.00K | -1.97M | -73.01% |
| Dec 31, 2022 | 2.70M | 2.61M | 2,964.77% |
| Dec 31, 2021 | 88.00K | 15.00K | 20.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Synbio Tech | 1.01B |
| GenMont Biotech Incorporation | 382.11M |
| Abnova (Taiwan) | 345.45M |
| NeoCore Technology | 277.54M |
| Sunny Pharmtech | 233.36M |
| G&E Herbal Biotechnology | 215.61M |
| Gwo Xi Stem Cell Applied Technology Co. , | 157.86M |
| TaiRx | 29.44M |